ReviewJournal of inflammation research2026
Traditional Chinese Medicine Modulation of Macrophage Polarization in Inflammation Associated with Coronary Heart Disease: Mechanisms and Challenges.
Review in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coronary heart disease (CHD) remains a leading cause of global mortality, with unresolved inflammation constituting a major residual risk after conventional therapies. Macrophage polarization, characterized by shifts between pro-inflammatory M1 and reparative M2 phenotypes, influences vascular inflammation, plaque stability, myocardial injury, and tissue repair, making it a potential therapeutic target in CHD. Traditional Chinese Medicine (TCM) is increasingly recognized for its multi-target immunomodulatory properties. This review systematically synthesizes the current evidence on the mechanisms by which TCM formulas and active ingredients regulate macrophage polarization to modulate the inflammatory response in CHD. Importantly, the stage-specific roles of TCM during the progression of CHD (atherosclerosis, acute myocardial infarction, ischemia-reperfusion injury, and post-infarct repair) are delineated. Emerging mechanistic insights into metabolic reprogramming, mitochondrial function, and epigenetic modifications are also highlighted. However, most evidence linking TCM to macrophage polarization in CHD is derived from cellular and animal studies, while direct clinical validation remains limited. Finally, current limitations, knowledge gaps, and future directions for basic research and clinical translation are discussed. By moving beyond descriptive pathway enumeration to an integrated framework that encompasses signaling networks, disease-stage dynamics, and deep molecular mechanisms, this review aims to provide a comprehensive reference for investigators and clinicians interested in TCM-based immunomodulatory strategies for CHD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.